Hematology TimesSerious side effect of AML treatment going unnoticed, FDA warnsNovember 30, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesEC approves product for hemophilia ANovember 29, 2018ThrombosisPharmacyBleeding Disorders
Hematology TimesEC approves mogamulizumab for MF, SSNovember 28, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesCanada expands approval for antihemophilic factorNovember 28, 2018ThrombosisPharmacyBleeding Disorders
Hematology TimesPegfilgrastim biosimilar approved by ECNovember 28, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
Hematology TimesEC approves pegfilgrastim biosimilarNovember 27, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
Hematology TimesFDA approves venetoclax for AMLNovember 21, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesFDA approves glasdegib for AMLNovember 21, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesFDA approves first treatment for primary HLHNovember 20, 2018AnemiaPediatricsPharmacy
Hematology TimesQuick FDA approval for brentuximab vedotin in PTCLNovember 16, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesFDA approves generic drugs for APLNovember 16, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesFDA and EC approve pegfilgrastim biosimilarNovember 4, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
